Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-24-258608
Filing Date
2024-11-14
Accepted
2024-11-14 16:19:49
Documents
4
Period of Report
2024-11-14

Document Format Files

Seq Description Document Type Size
1 6-K d827238d6k.htm 6-K 9366
2 EX-99.1 d827238dex991.htm EX-99.1 119821
3 GRAPHIC g827238g1115010800056.jpg GRAPHIC 2993
4 GRAPHIC g827238g1115010800386.jpg GRAPHIC 1285
  Complete submission text file 0001193125-24-258608.txt   136430
Mailing Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900 45 70 22 22 44
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

EIN.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36815 | Film No.: 241462739
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)